Unknown

Dataset Information

0

Dysbindin is a potent inducer of RhoA-SRF-mediated cardiomyocyte hypertrophy.


ABSTRACT: Dysbindin is an established schizophrenia susceptibility gene thoroughly studied in the context of the brain. We have previously shown through a yeast two-hybrid screen that it is also a cardiac binding partner of the intercalated disc protein Myozap. Because Dysbindin is highly expressed in the heart, we aimed here at deciphering its cardiac function. Using a serum response factor (SRF) response element reporter-driven luciferase assay, we identified a robust activation of SRF signaling by Dysbindin overexpression that was associated with significant up-regulation of SRF gene targets, such as Acta1 and Actc1. Concurrently, we identified RhoA as a novel binding partner of Dysbindin. Further phenotypic and mechanistic characterization revealed that Dysbindin induced cardiac hypertrophy via RhoA-SRF and MEK1-ERK1 signaling pathways. In conclusion, we show a novel cardiac role of Dysbindin in the activation of RhoA-SRF and MEK1-ERK1 signaling pathways and in the induction of cardiac hypertrophy. Future in vivo studies should examine the significance of Dysbindin in cardiomyopathy.

SUBMITTER: Rangrez AY 

PROVIDER: S-EPMC3840930 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-JCBD-201303052 | bioimages
| S-EPMC5473223 | biostudies-literature
| S-EPMC11303069 | biostudies-literature
| S-EPMC3808644 | biostudies-literature
| S-EPMC5927483 | biostudies-other
| S-EPMC3227540 | biostudies-literature
| S-EPMC7812832 | biostudies-literature
2019-11-30 | GSE141166 | GEO
| S-EPMC10651131 | biostudies-literature
| S-EPMC3822973 | biostudies-literature